Results 261 to 270 of about 20,388,994 (310)
Some of the next articles are maybe not open access.
The Prevalence of Hepatic Granulomas in Chronic Hepatitis C
Journal of Clinical Gastroenterology, 2004Hepatic granulomas are not usual findings in chronic hepatitis C. A few studies addressing the frequency of hepatic granulomas in chronic hepatitis C reported it as less than 10%. The presence of it has been suggested to predict a favorable response to interferon treatment.
Mert, A +10 more
openaire +4 more sources
Adiponectin in chronic hepatitis C
Clinical Journal of Gastroenterology, 2013White adipose tissue has been increasingly recognized as an important endocrine organ that secretes a number of biologically active adipokines. Adiponectin, one of the major adipokines, possesses anti-inflammatory and insulin-sensitizing properties, and its serum levels typically decline with increasing body weight.
Toru, Arano +3 more
openaire +2 more sources
Clinical Gastroenterology and Hepatology, 2005
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Winnie, Wong, Norah, Terrault
openaire +2 more sources
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Winnie, Wong, Norah, Terrault
openaire +2 more sources
Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
THERAPY FOR CHRONIC HEPATITIS C
Gastroenterology Clinics of North America, 1994Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients.
G L, Davis, J Y, Lau, H L, Lim
openaire +2 more sources
Therapy for chronic hepatitis C
Journal of Physiology-Paris, 2001in Hungary, over the past 5 years more than 900 patients with chronic hepatitis C have been examined for treatment with interferon at 16 major hepatology centres, using unified diagnostic and therapeutical criteria. Authors give an account of their experiences on the clinical features of patients with chronic hepatitis C and report the results of the ...
Pár, Alajos +3 more
openaire +3 more sources
Management of Chronic Hepatitis C
Journal of the American Academy of Nurse Practitioners, 2001One purpose of the Clinical Practice Guideline column is to increase the awareness of the broad availability of existing guidelines and recommendations on various health topics. The hepatitis C virus (HCV) currently accounts for 20% to 40% of acute viral hepatitis, 60% to 80% of chronic hepatitis, and 20% to 30% of cirrhosis, end‐stage liver disease ...
Mary Jo Goolsby, James Blackwell
openaire +2 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +2 more sources
Aminoadamantanes for chronic hepatitis C
Cochrane Database of Systematic Reviews, 2012Around 3% of the world's population (approximately 160 million people) are chronically infected with hepatitis C virus. The proportion of infected people who develop clinical symptoms varies between 5% and 40%. Combination therapy with pegylated interferon-alpha plus ribavirin eradicates the virus from the blood six months after treatment (sustained ...
Lamers, M.H. +5 more
openaire +3 more sources
Chronic Hepatitis C in Pregnancy
Obstetrics & Gynecology, 2008To estimate outcomes, to determine whether appropriate follow-up was performed for pregnant patients with hepatitis C virus (HCV), and to show that maternal and neonatal complications would be higher in the HCV-positive group.We compared pregnant women from a drug dependence and treatment program who were HCV antibody-positive with those who were HCV ...
Eliza M F, Berkley +4 more
openaire +2 more sources